Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (521-530 of 768) with videos related to

Pageof 77
Sort By:
Bone Marrow Transplantation|May 29, 2007
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignanciesE Ozdemir, R M Saliba, R E Champlin, et al.
The New England Journal of Medicine|May 9, 2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantationRoy F Chemaly, Andrew J Ullmann, Susanne Stoelben, et al.
Biomedical Microdevices|June 25, 2010
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cellsYoonsu Choi, Carrie Yuen, Sourindra N Maiti, et al.
Blood|May 4, 2007
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaHubert Schrezenmeier, Jakob R Passweg, Judith C W Marsh, et al.
Leukemia|September 23, 2016
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignanciesM H Qazilbash, E Wieder, P F Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Status of high-dose chemotherapy for breast cancer: a reviewY Nieto, R E Champlin, J R Wingard, et al.
Blood|October 22, 2005
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantationHanna J Khoury, Fausto R Loberiza, Olle Ringdén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2013
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remissionUlas D Bayraktar, Marcos de Lima, Rima M Saliba, et al.
Blood|July 10, 2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapyFarhad Ravandi, Jeffrey L Jorgensen, Deborah A Thomas, et al.
The American Journal of Surgical Pathology|August 24, 2017
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host DiseaseJin S Im, Susan C Abraham, Rima M Saliba, et al.
Pageof 77

Showing results (521-530 of 768) with videos related to

Sort By:
Pageof 77
Bone Marrow Transplantation|May 29, 2007
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignanciesE Ozdemir, R M Saliba, R E Champlin, et al.
The New England Journal of Medicine|May 9, 2014
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantationRoy F Chemaly, Andrew J Ullmann, Susanne Stoelben, et al.
Biomedical Microdevices|June 25, 2010
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cellsYoonsu Choi, Carrie Yuen, Sourindra N Maiti, et al.
Blood|May 4, 2007
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaHubert Schrezenmeier, Jakob R Passweg, Judith C W Marsh, et al.
Leukemia|September 23, 2016
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignanciesM H Qazilbash, E Wieder, P F Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Status of high-dose chemotherapy for breast cancer: a reviewY Nieto, R E Champlin, J R Wingard, et al.
Blood|October 22, 2005
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantationHanna J Khoury, Fausto R Loberiza, Olle Ringdén, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2013
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remissionUlas D Bayraktar, Marcos de Lima, Rima M Saliba, et al.
Blood|July 10, 2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapyFarhad Ravandi, Jeffrey L Jorgensen, Deborah A Thomas, et al.
The American Journal of Surgical Pathology|August 24, 2017
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host DiseaseJin S Im, Susan C Abraham, Rima M Saliba, et al.
Pageof 77